[<sup>18</sup>F]FES PET Resolves the Diagnostic Dilemma of COVID-19-Vaccine-Associated Hypermetabolic Lymphadenopathy in ER-Positive Breast Cancer

[<sup>18</sup>F]FES PET Resolves the Diagnostic Dilemma of COVID-19-Vaccine-Associated Hypermetabolic Lymphadenopathy in ER-Positive Breast Cancer

Coronavirus disease (COVID-19) vaccination is known to cause a diagnostic dilemma due to false-positive findings on [<sup>18</sup>F]FDG PET in vaccine-associated hypermetabolic lymphadenopathy. We present two case reports of women with estrogen-receptor (ER)-positive cancer of the breast...

Full description

Bibliographic Details
Main Authors: Munenobu Nogami, Tetsuya Tsujikawa, Hiroyuki Maeda, Nobuyuki Kosaka, Mizuho Takahashi, Naoki Kinoshita, Tetsuya Mori, Akira Makino, Yasushi Kiyono, Takamichi Murakami, Takanori Goi, Hidehiko Okazawa
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Diagnostics
Subjects:
COVID-19
vaccination
lymphadenopathy
FES PET
breast cancer
Online Access:https://www.mdpi.com/2075-4418/13/11/1851

Internet

https://www.mdpi.com/2075-4418/13/11/1851

Similar Items